Carlisle Companies Inc (CSL)

106.90
NYSE : Consumer Goods
Prev Close 106.90
Day Low/High 0.00 / 0.00
52 Wk Low/High 96.55 / 116.40
Avg Volume 428.30K
Exchange NYSE
Shares Outstanding 64.59M
Market Cap 6.88B
EPS 3.90
P/E Ratio 27.83
Div & Yield 1.40 (1.30%)

Latest News

Carlisle Companies Appoints Robert M. Roche Vice President And Chief Financial Officer Effective February 15, 2017

Carlisle Companies Appoints Robert M. Roche Vice President And Chief Financial Officer Effective February 15, 2017

Carlisle Companies Incorporated (NYSE:CSL) is pleased to announce the appointment of Robert M.

Carlisle Reports Fourth Quarter And Full Year 2016 Results

Carlisle Reports Fourth Quarter And Full Year 2016 Results

Carlisle Companies Incorporated (NYSE:CSL) reported record net sales of $893.

Carlisle Companies Declares Regular Quarterly Dividend

Carlisle Companies Declares Regular Quarterly Dividend

The Board of Directors of Carlisle Companies Incorporated (NYSE:CSL) has declared a regular quarterly dividend of $0.

Carlisle Companies Acquires Arbo Holdings Limited

Carlisle Companies Acquires Arbo Holdings Limited

Carlisle Companies Incorporated (NYSE:CSL) today announced the acquisition of Arbo Holdings Limited, a leading provider of sealants, coatings and membrane systems used by architects and contractors for waterproofing and...

Short Interest Falls 26% For CSL

Short Interest Falls 26% For CSL

The most recent short interest data has been released for the 12/30/2016 settlement date, which shows a 460,234 share decrease in total short interest for Carlisle Companies Inc. , to 1,303,008, a decrease of 26.10% since 12/15/2016.

Carlisle Companies Acquires San Jamar

Carlisle Companies Acquires San Jamar

Carlisle Companies Incorporated (NYSE:CSL) today announced the acquisition of San Jamar, Inc.

AFSTYLA®, For Haemophilia A, Receives European Commission Approval

AFSTYLA®, For Haemophilia A, Receives European Commission Approval

- CSL Behring's AFSTYLA is the first and only single-chain therapy for haemophilia A

Carlisle Companies To Announce 4th Quarter Results On February 9, 2017

Carlisle Companies To Announce 4th Quarter Results On February 9, 2017

Carlisle Companies Incorporated (NYSE:CSL) will release fourth quarter 2016 results on Thursday, February 9, 2017 after the market closes.

CSL CEO Says Holistic Approach To Business Is Essential To Corporate Sustainability, The Company's Value Chain And Patients

CSL CEO Says Holistic Approach To Business Is Essential To Corporate Sustainability, The Company's Value Chain And Patients

The global biotherapeutics company released its 2015-2016 Corporate Responsibility Report, which details company performance in key social, environmental and economic priority areas.

Carlisle Crew In La Gomera Preparing For The Race. L-R: Matt Brown, Alex Simpson, Angus Collins, Jason Caldwell

Carlisle Crew In La Gomera Preparing For The Race. L-R: Matt Brown, Alex Simpson, Angus Collins, Jason Caldwell

Carlisle Companies Incorporated (NYSE:CSL) announced that the Crew of the American Spirit will begin to row across the Atlantic Ocean on December 14 in the Atlantic Challenge, known as the "World's Toughest Row.

CSL Behring Presents New Phase III Analysis Of IDELVION® For Hemophilia B At The 2016 American Society Of Hematology Annual Meeting

CSL Behring Presents New Phase III Analysis Of IDELVION® For Hemophilia B At The 2016 American Society Of Hematology Annual Meeting

- Analysis of clinical trial efficacy results and estimated factor IX levels suggests that patients who maintain factor IX activity levels above 5 and 10 percent have significantly reduced bleeding risk

CSL Behring Presents Positive Results From The CSL112 AEGIS-I Phase 2b Trial

CSL Behring Presents Positive Results From The CSL112 AEGIS-I Phase 2b Trial

Study Meets Co-Primary Endpoints of Hepatic and Renal Safety and Demonstrates Proof of Mechanism

AFSTYLA®, For Haemophilia A, Receives Positive Opinion From European Medicines Agency CHMP

AFSTYLA®, For Haemophilia A, Receives Positive Opinion From European Medicines Agency CHMP

-- CHMP positive opinion moves AFSTYLA one step closer to approval in the European Union

Carlisle Companies Declares Regular Quarterly Dividend

Carlisle Companies Declares Regular Quarterly Dividend

The Board of Directors of Carlisle Companies Incorporated (NYSE:CSL) has declared a regular quarterly dividend of $0.

Carlisle Companies To Present At Baird Industrial Conference In Chicago On November 8

Carlisle Companies To Present At Baird Industrial Conference In Chicago On November 8

D. Christian "Chris" Koch, President and Chief Executive Officer of Carlisle Companies Incorporated (NYSE:CSL), will be presenting at the Baird Industrial Conference at the Four Seasons Hotel in Chicago, IL at 10:00 a.

Jim Cramer's 'Mad Money' Recap: Credibility Is the Most Valuable Currency for Investors

Jim Cramer's 'Mad Money' Recap: Credibility Is the Most Valuable Currency for Investors

Jim Cramer names companies with credibility, like NXPI and AAPL, and those that don't have it, including FIT.

CSL Behring Receives 2016 Marcum Innovator Breakthrough Award For Pioneering New Advancements In The Biotech/Healthcare Field

CSL Behring Receives 2016 Marcum Innovator Breakthrough Award For Pioneering New Advancements In The Biotech/Healthcare Field

One of the world's top specialty biotherapeutics companies, CSL Behring continues to introduce innovations to address unmet medical needs or enhance current treatments.

Carlisle Reports Loss Per Share From Continuing Operations In Third Quarter Of $0.15, Including Non-Cash Impairment Charges

Carlisle Reports Loss Per Share From Continuing Operations In Third Quarter Of $0.15, Including Non-Cash Impairment Charges

Carlisle Companies Incorporated (NYSE:CSL) reported net sales of $991.

Practicing In The Cold Ocean Waters Of The San Francisco Bay, California, The Crew Of Carlisle's American Spirit Prepares For Their Trans-Atlantic Race In December, Rowing 3000 Nautical Miles From The Canary Islands To Antigua. (Photo: Business Wire)

Practicing In The Cold Ocean Waters Of The San Francisco Bay, California, The Crew Of Carlisle's American Spirit Prepares For Their Trans-Atlantic Race In December, Rowing 3000 Nautical Miles From The Canary Islands To Antigua. (Photo: Business Wire)

Carlisle Companies Incorporated's (NYSE:CSL) American Spirit is preparing to row across the Atlantic Ocean in the Atlantic Challenge, where the competitors will begin this major nautical event on December 15.

Carlisle Companies Acquires Star Aviation

Carlisle Companies Acquires Star Aviation

Carlisle Companies Incorporated (NYSE:CSL) today announced the acquisition of Star Aviation, Inc.

Japan's Ministry Of Health, Labour And Welfare (MHLW) Approves CSL Behring's IDELVION® -- The First And Only Hemophilia B Therapy With Up To 14-day Dosing Intervals

Japan's Ministry Of Health, Labour And Welfare (MHLW) Approves CSL Behring's IDELVION® -- The First And Only Hemophilia B Therapy With Up To 14-day Dosing Intervals

- IDELVION delivers high-level protection from bleeds by maintaining factor IX activity levels at an average of 20 percent in patients treated prophylactically every 7-days and an average of 12 percent every 14-days

Carlisle Companies To Announce 3rd Quarter Results On October 25, 2016

Carlisle Companies To Announce 3rd Quarter Results On October 25, 2016

Carlisle Companies Incorporated (NYSE:CSL) will release third quarter 2016 results on Tuesday, October 25, 2016 after the market closes.

Carlisle Authorizes Repurchase Of An Additional 4.1 Million Shares

Carlisle Authorizes Repurchase Of An Additional 4.1 Million Shares

The Board of Directors of Carlisle Companies Incorporated (NYSE:CSL) has authorized Carlisle to repurchase an additional 4.

Carlisle Companies Elects Jonathan Collins To Board Of Directors

Carlisle Companies Elects Jonathan Collins To Board Of Directors

Carlisle Companies Incorporated (NYSE:CSL) announced today that Jonathan Collins, Vice President and Head of eCommerce for Mylan N.